Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research - Hamburg, Germany

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity Clinical Research – Hamburg (PPDS) is a dedicated clinical trial research site located in Hamburg, Germany. The facility is part of Velocity Clinical Research Germany GmbH, a global integrated site organization that partners with pharmaceutical and biotechnology companies to conduct clinical trials for new drugs, medical devices, and diagnostic technologies. The Hamburg site was originally founded in 2004 as Clinical Research Hamburg GmbH and later became part of Velocity Clinical Research in 2022, strengthening the organization’s clinical research network in Europe. The site conducts Phase II–IV clinical trials across multiple therapeutic areas including dermatology, orthopedics, gynecology, internal medicine, and general medicine. It collaborates closely with local physicians and healthcare networks to support efficient patient recruitment and high-quality clinical research. The facility is equipped with modern research infrastructure such as patient consultation rooms,…

Source: Trial-derived.
3Total Trials
Source: Trial-derived.
0Recruiting Trials
Source: Trial-derived.
1Active Trials
Source: Trial-derived.
1Completed Trials
Source: Trial-derived.
4Unique Conditions
Source: Trial-derived.
3Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Cytomegalovirus Infection (1)Source: Trial-derived. Influenza, Human (1)Source: Trial-derived. Obesity (1)Source: Trial-derived. Overweight (1)

Sponsors

Source: Trial-derived. Eli Lilly and Company (1)Source: Trial-derived. ModernaTX, Inc. (1)Source: Trial-derived. Seqirus (1)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. PCR / molecular

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Virus neutralisation antibody assay